Nonalcoholic Steatohepatitis Completed Phase 2 / 3 Trials for Pentoxifylline (DB00806)

IndicationStatusPhase
DBCOND0029353 (Nonalcoholic Steatohepatitis)Completed2 / 3
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00267670Pentoxifylline/Nonalcoholic Steatohepatitis (NASH) Study: The Effect of Pentoxifylline on NASHTreatment